Clomifene Citrate (Ova-Mit) is contra-indicated during pregnancy. To avoid inadvertent Clomifene Citrate (Ova-Mit) administration during early pregnancy, the patient should be carefully observed to determine if ovulation occurs. The basal body temperature should be recorded throughout all treatment cycles, and Clomifene Citrate (Ova-Mit) therapy should be discontinued if pregnancy is suspected.